Skip to content

Multicenter Study of the Protector Laryngeal Mask

A Multicenter Study of the Protector Laryngeal Mask in Non Paralyzed, Anesthetized Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03272776
Enrollment
280
Registered
2017-09-06
Start date
2017-08-01
Completion date
2018-07-30
Last updated
2019-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway

Keywords

LMA Protector, Second Generation Laryngeal Masks, Airway, Dual Gastric Acces, Teleflex, Supraglottic Devices, Ambulatory Surgery

Brief summary

The study was designed to evaluate the success rate, time of insertion, sealing efficacy and security of the Protector Laryngeal Mask, a new second generation disposable supraglottic airway device, in patients undergoing elective surgery.

Detailed description

Laryngeal masks (LM) and supraglottic devices (SGD), in all their different forms, have become an authentic innovation in airway management especially in day surgery. LMA Protector (Teleflex Medical, Athlone, Ireland) is a new disposable SGD currently available for anaesthetic practice. It is made of silicone (with no latex in its composition) and shares some of the characteristics of the second generation SGDs (as the presence of a gastric access channel); however, it has an additional drainage channel, both channels terminate distally in a camera behind the mask cuff. The presence of two drainage channels (male and female) increases the patient safety against regurgitation, both of distal gastric content and secretions located in the oropharyngeal region. The gastric access channel called female also allows the insertion of a nasogastric tube if required. These drainage channels are useful for diagnosing the correct position of the mask, since the observation of leaks or gas through it can help diagnose a displacement the mask. LMA Protector is designed with a preformed anatomic curve, and the airway conduct has an elliptical cross section, which ends distally in the mask. This design follows the anatomy of the human airway, which facilitates the insertion of the device. The softness of the mask material allows easy insertion. Doubts regarding the transmission of infectious diseases with reusable devices makes disposable devices such as LMA Protector, one of the most interesting devices for use in anaesthetic procedures that are usually performed with SGD. Its characteristics in the design, composition by a smooth and atraumatic material, the presence of two gastric drainage accesses, with potential improved patient safety and its characteristic of being disposable suggests a significant expansion of its use in the coming years . In contrast to other SGDs that have been evaluated extensively, to date there are no large clinical studies showing its suitably and performance in a daily clinical scenario.

Interventions

DEVICEProtector Laryngeal Mask airway

Evaluate the time of insertion, performance, security and insertion success rate of the Protector Laryngeal Mask in patients under general anasthesia.

Sponsors

Teleflex
CollaboratorINDUSTRY
Matilde Zaballos
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Surgery procedures usually performed with supraglottic devices. * ASA physical status I-III patients * Age 18-75 * Signed inform consent

Exclusion criteria

* Patients with known difficult airway * Patients with predicted difficult airway * Patients with increased risk of aspiration * Patient refusal to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Evaluate the number of attempts to insert of the LMA ProtectorThe number of insertion attempts will be collected after anesthesia induction: 1 minute after the administration of propofolInsertion attempts: from picking up the LMA Protector until the mask is placed into the patient mouth . (in numbers)

Secondary

MeasureTime frameDescription
Blood pressure during insertion of LMA protectBaseline and every 3 minutes until 6 minutes after insertion of the LMA protectorBlood pressure in mmHg
Heart rate during insertion of LMA protectBaseline and every 3 minutes until 6 minutes after insertion of the LMA protectorheart rate in beep per minute
BIS dataBaseline and every 3 minutes until 6 minutes after insertion of the LMA protector (To evaluate the evolution of BIS values during insertion of the LMAnumber from 100 (awake) to 40-45 (anesthetic status)
Oropharyngeal leak pressure of the LMA ProtectorThe Oropharyngeal leak pressure of the LMA Protector will be collected 5 minutes after the LMA Protector will be insertedThe Oropharyngeal leak pressure of the LMA Protector will be determined with an intracuff pressure of 60 cm H2O by closing the expiratory valve of the breathing circle circuit at a fixed gas flow of 3 L/min and noting the pressure at which an oropharyngeal leak occurs. (in cm H2O)

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026